DEBRA ABERDALE: Open Payments
NPI 1942399332 · TROY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,039 in 68 payments from 18 companies in 2025. Trend: 2023 $191 · 2024 $547 · 2025 $1,039
Food & beverage: $1,039
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 19 | $254 |
| ABBVIE INC. | 17 | $172 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $134 |
| Phathom Pharmaceuticals, Inc. | 11 | $87 |
| Gilead Sciences, Inc. | 2 | $50 |
| Madrigal Pharmaceuticals | 1 | $43 |
| GENZYME CORPORATION | 1 | $35 |
| Ipsen Biopharmaceuticals, Inc | 1 | $32 |
| QOL Medical, LLC | 1 | $32 |
| Ardelyx, Inc. | 1 | $32 |
Products named: TREMFYA, RINVOQ, ENTYVIO, VOQUEZNA, LINZESS, EOHILIA, REZDIFFRA, DUPIXENT.
Industry payments across NY — which companies pay providers there.
